z-logo
open-access-imgOpen Access
Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single institute
Author(s) -
Takaya Yamamoto,
Yoshihide Kawasaki,
Rei Umezawa,
Noriyuki Kadoya,
Haruo Matsushita,
Kazuya Takeda,
Yojiro Ishikawa,
Noriyoshi Takahashi,
Yu Suzuki,
Ken Takeda,
Kohsuke Kawabata,
Akihiro Ito,
Keiichi Jingu
Publication year - 2021
Publication title -
journal of radiation research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.643
H-Index - 60
eISSN - 1349-9157
pISSN - 0449-3060
DOI - 10.1093/jrr/rrab031
Subject(s) - medicine , log rank test , survival rate , cancer , retrospective cohort study , radiation therapy , kidney cancer , nuclear medicine , oncology , urology , overall survival , surgery , radiology
The purpose of this retrospective study was to investigate survival outcomes and irradiated tumor control (local control [LC]) and locoregional control (LRC) after stereotactic body radiotherapy (SBRT) for T1 or recurrent T1 (rT1) kidney cancer. Twenty-nine nonconsecutive patients with 30 tumors were included. SBRT doses of 70 Gy, 60 Gy or 50 Gy in 10 fractions were prescribed with a linear accelerator using daily image guidance. The Kaplan-Meier method was used to estimate time-to-event outcomes, and the log-rank test was used to compare survival curves between groups divided by each possible factor. The median follow-up periods for all patients and survivors were 57 months and 69.6 months, respectively. The five-year LC rate, LRC rate, progression-free survival (PFS) rate, disease-specific survival (DSS) rate and overall survival (OS) rate were 94%, 88%, 50%, 96% and 68%, respectively. No significant factor was related to OS and PFS. Three of 24 non-hemodialysis (HD) patients had new-onset-HD because of the progression of underlying kidney disease. Grade 3 or higher toxicities from SBRT did not occur. In conclusion, SBRT for kidney cancer provided a high rate of LC, LRC and DSS with minimal toxicities, but patient selection and indication for SBRT should be done carefully considering the relatively low OS rate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here